BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34048792)

  • 1. Pain Intensity and Pain Interference in People With Progressive Multiple Sclerosis Compared With People With Relapsing-Remitting Multiple Sclerosis.
    Knowles LM; Phillips KM; Herring TE; Alschuler KN; Jensen MP; Turner AP; Ehde DM
    Arch Phys Med Rehabil; 2021 Oct; 102(10):1959-1964. PubMed ID: 34048792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in correlates of fatigue between relapsing and progressive forms of multiple sclerosis.
    Herring TE; Alschuler KN; Knowles LM; Phillips KM; Morean WM; Turner AP; Ehde DM
    Mult Scler Relat Disord; 2021 Sep; 54():103109. PubMed ID: 34237561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressive Symptoms and Suicidal Ideation in Progressive Multiple Sclerosis Compared With Relapsing-Remitting Multiple Sclerosis: Results From a Cross-sectional Survey.
    Knowles LM; Esselman EC; Turner AP; Phillips KM; Herring TE; Alschuler KN; Ehde DM
    Arch Phys Med Rehabil; 2021 Apr; 102(4):694-701. PubMed ID: 33080210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of anxiety symptoms and correlates of anxiety in people with progressive and relapsing-remitting multiple sclerosis.
    Knowles LM; Tingey JL; Newman AK; von Geldern G; Alschuler KN
    Mult Scler Relat Disord; 2022 Jul; 63():103918. PubMed ID: 35700673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid foot-tapping but not hand-tapping ability is different between relapsing-remitting and progressive multiple sclerosis.
    Sato S; Lim J; Miehm JD; Buonaccorsi J; Rajala C; Khalighinejad F; Ionete C; Kent JA; van Emmerik REA
    Mult Scler Relat Disord; 2020 Jun; 41():102031. PubMed ID: 32172213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes are worse for progressive-onset multiple sclerosis than relapse-onset multiple sclerosis, particularly early in the disease process.
    Zhang Y; Taylor BV; Simpson S; Blizzard L; van der Mei I
    Eur J Neurol; 2019 Jan; 26(1):155-161. PubMed ID: 30133059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis.
    Feys P; Bibby BM; Baert I; Dalgas U
    Eur J Phys Rehabil Med; 2015 Apr; 51(2):207-10. PubMed ID: 25180640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Demographic and Clinical Factors in Cognitive Functioning of Persons with Relapsing-Remitting and Progressive Multiple Sclerosis.
    Costa SL; DeLuca J; Sandroff BM; Goverover Y; Chiaravalloti ND
    J Int Neuropsychol Soc; 2018 Feb; 24(2):139-146. PubMed ID: 28830576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic approach to analyse health-related quality of life in multiple sclerosis: the GEDMA study.
    Morales-Gonzáles JM; Benito-León J; Rivera-Navarro J; Mitchell AJ;
    Mult Scler; 2004 Feb; 10(1):47-54. PubMed ID: 14760952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort.
    Tilling K; Lawton M; Robertson N; Tremlett H; Zhu F; Harding K; Oger J; Ben-Shlomo Y
    Health Technol Assess; 2016 Oct; 20(81):1-48. PubMed ID: 27817792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
    Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira À; Montalban X; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Comi G; Filippi M;
    Neurology; 2019 Nov; 93(20):e1852-e1866. PubMed ID: 31611336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab for relapsing-remitting multiple sclerosis.
    He D; Guo R; Zhang F; Zhang C; Dong S; Zhou H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD009130. PubMed ID: 24310855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain in women with relapsing-remitting multiple sclerosis and in healthy women: a comparative study.
    Newland P
    J Neurosci Nurs; 2008 Oct; 40(5):262-8. PubMed ID: 18856246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assessment of people with relapsing-remitting and progressive multiple sclerosis towards burden of disease, progression, and treatment utilization-Results of a large-scale cross-sectional online survey (MS Perspectives).
    Bayas A; Schuh K; Christ M
    Mult Scler Relat Disord; 2022 Dec; 68():104166. PubMed ID: 36115289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.
    Planche V; Gibelin M; Cregut D; Pereira B; Clavelou P
    Eur J Neurol; 2016 Feb; 23(2):282-9. PubMed ID: 25903918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teriflunomide for multiple sclerosis.
    He D; Xu Z; Dong S; Zhang H; Zhou H; Wang L; Zhang S
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009882. PubMed ID: 23235682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body temperature is elevated and linked to fatigue in relapsing-remitting multiple sclerosis, even without heat exposure.
    Sumowski JF; Leavitt VM
    Arch Phys Med Rehabil; 2014 Jul; 95(7):1298-302. PubMed ID: 24561056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-sectional study on the relationship between cardiorespiratory fitness, disease severity and walking speed in persons with Multiple Sclerosis.
    Madsen LT; Dalgas U; Hvid LG; Bansi J
    Mult Scler Relat Disord; 2019 Apr; 29():35-40. PubMed ID: 30658262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T.
    Inglese M; Park SJ; Johnson G; Babb JS; Miles L; Jaggi H; Herbert J; Grossman RI
    Arch Neurol; 2007 Feb; 64(2):196-202. PubMed ID: 17296835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.